Hilla Yaish
About Hilla Yaish
Hilla Yaish is the Manager of Market Access at Bristol Myers Squibb in Israel, with over a decade of experience in the healthcare and pharmaceutical industry.
Current Role at Bristol Myers Squibb
Hilla Yaish currently serves as Manager of Market Access at Bristol Myers Squibb in Israel. She has been in this role since June 2021. As Manager of Market Access, she is responsible for facilitating the accessibility of pharmaceutical products in the market, ensuring compliance with local regulations, and working on strategies to maximize market penetration.
Previous Experience at Bristol Myers Squibb
Before her current role, Hilla Yaish was the Manager of Medical at Bristol Myers Squibb from 2019 to 2021. During this period, she focused on medical affairs, aligning clinical research with regulatory requirements, and collaborating with healthcare professionals to support medical and scientific communications.
Experience at Sheba - Tel Ha SHomer Hospital
Hilla Yaish spent a significant portion of her career at Sheba - Tel Ha SHomer Hospital. She worked as Head of Quality Assurance from 2016 to 2019, where she ensured the quality and regulatory compliance of clinical operations. Prior to that, she was the Lead Study Coordinator in the Oncology Institute, focusing on ovary and breast cancer clinical trials from 2008 to 2016.
Educational Background
Hilla Yaish holds a Master of Business Administration (MBA) from Edinburgh Business School, Heriot-Watt University, earned between 2009 and 2012. She also has a Bachelor of Science (BS) degree in Life Science and Management from The Open University, completed between 2003 and 2007. Her educational background provides a strong foundation in both scientific and business disciplines.
Combined Expertise in Life Sciences and Business Management
Hilla Yaish combines over a decade of experience in the healthcare and pharmaceutical industry with a strong educational background in both life sciences and business management. This dual expertise allows her to navigate complex regulatory environments and market access strategies effectively, making her a valuable asset in her current role.